Marshall Wace’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Buy
1,198,551
+38,200
+3% +$50.2K ﹤0.01% 1837
2025
Q4
$1.44M Buy
1,160,351
+865,618
+294% +$1.21M ﹤0.01% 1755
2025
Q3
$595K Buy
294,733
+260,517
+761% +$477K ﹤0.01% 2164
2025
Q2
$61.6K Buy
34,216
+5,750
+20% +$11.1K ﹤0.01% 2581
2025
Q1
$60.6K Sell
28,466
-94,847
-77% -$323K ﹤0.01% 2524
2024
Q4
$478K Sell
123,313
-121,412
-50% -$967K ﹤0.01% 2046
2024
Q3
$2.47M Buy
244,725
+206,053
+533% +$1.34M ﹤0.01% 1288
2024
Q2
$174K Sell
38,672
-3,900
-9% -$39.6K ﹤0.01% 2320
2024
Q1
$636K Sell
42,572
-196,967
-82% -$3.24M ﹤0.01% 1839
2023
Q4
$3.48M Buy
+239,539
New +$2.91M 0.01% 1038
2023
Q2
Sell
-10,776
Closed -$334K 2488
2023
Q1
$334K Sell
10,776
-12,162
-53% -$151K ﹤0.01% 2255
2022
Q4
$193K Buy
+22,938
New +$196K ﹤0.01% 2708

Other funds holding BMEA

Marshall Wace's BMEA Position: Q1 2026 in Review

Marshall Wace increased its Biomea Fusion (BMEA) stake by 3.3% in Q1 2026, buying an estimated $50.2K and bringing the position to 1,198,551 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1837.

Marshall Wace first reported a position in BMEA in Q4 2022 and has held it in 12 quarters since. The position peaked at $3.48M in Q4 2023. 65 funds tracked by Wall St. Rank hold BMEA as of Q1 2026.

  • Marshall Wace held 1,198,551 shares of Biomea Fusion worth $1.83M as of Q1 2026.
  • Marshall Wace bought 38,200 Biomea Fusion shares in Q1 2026, an estimated $50.2K.
  • Biomea Fusion made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1837 holding.
  • Marshall Wace first reported a position in Biomea Fusion in Q4 2022 and has held it in 12 quarters since.
  • Marshall Wace's Biomea Fusion position peaked at $3.48M in Q4 2023.
  • 65 funds tracked by Wall St. Rank held Biomea Fusion as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.